WIN $150 GIFT VOUCHERS: ALADDIN'S GOLD

Close Notification

Your cart does not contain any items

$150.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Elsevier - Health Sciences Division
25 January 2022
on VitalSource (Retail Access Card) on VitalSource (Retail Access Card)
Edited by:  
Imprint:   Elsevier - Health Sciences Division
Country of Publication:   United States
Dimensions:   Height: 235mm,  Width: 191mm, 
Weight:   570g
ISBN:   9780323827539
ISBN 10:   0323827535
Pages:   258
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
Section 1: What is Dry Eye Disease (DED)? 1 What is Dry Eye Disease: Evolving Definitions and Epidemiology 2 Questionnaires Used to Assess Dry Eye Disease 3 Clinical Assessment of Dry Eye Disease: Tear Film and Ocular Surface Health 4 Clinical Assessment of Dry Eye Disease: Nerve Health 5 Pathophsiology of Dry Eye Disease using Animal Models 6 Pathophsiology of Dry Eye Disease using Human Models Section 2: Dry Eye Disease (DED) in Specific Populations 7 Sjoegrens and Dry Eye Disease 8 Graft versus Host and Dry Eye Disease 9 Meibomian Gland Dysfunction and Dry Eye Disease 10 Systemic Pain Conditions and Dry Eye Disease 11 Ocular Conditions and Dry Eye Disease Section 3: Treatment of Dry Eye Disease (DEF) 12 Treatment of Dry Eye Disease in the United States 13 Treatment of Dry Eye Disease in Asia 14 Treatment of Dry Eye Disease in Europe 15 Treatment of Ocular Pain Not Responsive to Traditional Dry Eye Disease Treatments

Dr. Galor is a cornea and uveitis trained specialist with a dual appointment at the Miami Veterans Affairs (VA) medical center and the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. Dr. Galor completed an ophthalmology residency at the Cole Eye Cleveland Clinic, a uveitis fellowship at the Wilmer Eye Institute, Johns Hopkins University, and a cornea and external diseases fellowship at Bascom Palmer Eye Institute. Dr. Galor currently runs the ocular surface program at the Miami VA and has focused her research on understanding mechanisms of pain in dry eye, with an emphasis on studying new diagnostic and treatment modalities. She has lectured and published extensively on how nerve status may underlie the often noted disconnect between dry eye symptoms and signs. This includes individuals with decreased sensation and chronic epithelial abnormalities (neurotrophic phenotype) and individuals with hyper-sensitive nerves and chronic ocular pain with minimal ocular surface abnormalities (neuropathic phenotype). Over the years, she has participated in several dry eye related committees including the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) II Pain and Sensation Committee and the Dry Eye Awareness Month Congressional Briefing. In addition, she served as President of the Ocular Microbiology and Immunology Group and sits on several educational committees within the Academy of Ophthalmology.

See Also